Adaptyv
YC S21 ↗Lausanne, CH · Founded 2021 · 25 employees · 7 known investors
Adaptyv Bio develops technologies for protein engineering that enable the design and testing of new proteins for applications in medicine, industrial enzymes, and functional materials. The company serves protein engineers and researchers developing therapeutic and industrial biological products.
AI & Machine LearningBiotechDeep TechHealthtechAI-powered Drug DiscoverySynthetic Biologyin /adaptyvbio@adaptyvbioycombinator.com ↗
Founders & leadership· Y Combinator alumni (S21)
Investors · 7
In the news
- Adaptyv raises USD 8 million | GGBaggba.swiss · 2025
- Adaptyv Raises CHF 6,40 million to Accelerate AI-Driven Protein Validation - BioAlpsbioalps.org · 2025
- ACE Ventures Leads $8 Million Seed Round in Adaptyv Bio to Accelerate the Future of Protein Design - ACE Venturesaceventures.vc · 2025
- Adaptyv is the cloud lab for protein designers — and now available for everyone | Adaptyv Bioadaptyvbio.com · 2025
- Democratising The Science Of Protein Design With Adaptyv Bioforbes.com · 2023